The Kadar-Sheba Prize for Excellence in Research has recognized three leading Israeli physician-scientists whose work bridges scientific discovery and clinical medicine to advance patient care: Prof. Dana Wolf of Hadassah Medical Center, the 2025 laureate, and Prof. Benjamin Dekel and Prof. Asaf Vivante of Sheba Medical Center, the joint 2026 laureates.
Established by the Naomi Prawer Kadar Foundation in partnership with Sheba Medical Center, the Kadar-Sheba Prize recognizes outstanding physician-scientists in Israel who combine clinical care with scientific research and translate discoveries into meaningful advances for patients. The prize reflects a commitment to recognizing and strengthening the extraordinary medical and scientific talent within Israel’s healthcare and research ecosystem.
“We are very proud to be here {at the award ceremony} representing the award and our family,” said Maya Kadar Kovalsky, who sits on the board of the Naomi Foundation with her siblings Nadav Kadar and Dr. Einat Kadar-Kricheli, and their father, Dr. Avraham Kadar. “We believe in the power of exceptional individuals, like these physician-researchers, to make a difference in Israel and far beyond.”
From Scientific Questions to Better Care
At Sheba Medical Center, Prof. Benjamin Dekel and Prof. Asaf Vivante represent two generations of physician-scientists advancing the understanding and treatment of kidney disease.
Prof. Dekel, Director of Pediatric Nephrology at Safra Children’s Hospital and founder of its Institute for Stem Cell Research in Children, was recognized for pioneering work in kidney development, regenerative nephrology and organoid biology. His research connects kidney development, congenital disease, pediatric cancer and regeneration, using advanced human-based models to investigate disease and pursue new therapeutic approaches.
Prof. Vivante, Director of Pediatrics at Safra Children’s Hospital, was recognized for achievements in nephrogenetics, kidney-disease genetics and personalized medicine. His work connects genetic discovery with the diagnosis and treatment of patients with kidney failure and has helped establish a nationwide translational research framework spanning children and adults throughout Israel.
Their relationship also reflects the generational impact of scientific mentorship. Prof. Dekel has trained physician-scientists who are helping shape the future of medicine and science, while the 2026 award recognizes Prof. Dekel and Prof. Vivante together as mentor and student.
The 2025 laureate, Prof. Dana Wolf, Director of the Clinical Virology Unit at Hadassah Medical Center and a professor at the Hebrew University of Jerusalem, was recognized for achievements in clinical virology and research into congenital cytomegalovirus (CMV). Her work has contributed to advances spanning antiviral resistance, diagnostics and congenital CMV screening.
Excellence, Inquiry and Impact
“Israeli research is at the forefront of global science and medicine, thanks to outstanding researchers who dare to ask questions, challenge established thinking and pursue new solutions,” said Prof. Dror Harats, Deputy Director General for Research and Development and Head of the Research Authority at Sheba Medical Center. “The Kadar-Sheba Prize is intended not only to recognize exceptional achievements, but also to encourage, incentivize and empower the next generation of discoveries.”
The laureates exemplify the physician-scientist model at the heart of the Kadar-Sheba Prize: clinicians whose experience caring for patients informs the questions they pursue through research, and whose discoveries can ultimately create new possibilities for diagnosis, treatment and care.